Extendicare (EXE) Competitors C$10.14 +0.13 (+1.30%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and TLRYShould you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Tilray Brands (TLRY). These companies are all part of the "medical" sector. Extendicare vs. dentalcorp Sienna Senior Living WELL Health Technologies Medical Facilities KDA Group Nova Leap Health Premier Health of America BELLUS Health Trillium Therapeutics Tilray Brands dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings. Does the MarketBeat Community favor DNTL or EXE? Extendicare received 122 more outperform votes than dentalcorp when rated by MarketBeat users. However, 60.42% of users gave dentalcorp an outperform vote while only 48.24% of users gave Extendicare an outperform vote. CompanyUnderperformOutperformdentalcorpOutperform Votes2960.42% Underperform Votes1939.58% ExtendicareOutperform Votes15148.24% Underperform Votes16251.76% Is DNTL or EXE more profitable? Extendicare has a net margin of 4.28% compared to dentalcorp's net margin of -4.66%. Extendicare's return on equity of 60.00% beat dentalcorp's return on equity.Company Net Margins Return on Equity Return on Assets dentalcorp-4.66% -3.91% 0.77% Extendicare 4.28%60.00%7.16% Which has more risk & volatility, DNTL or EXE? dentalcorp has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Which has higher earnings and valuation, DNTL or EXE? Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiodentalcorpC$1.47B1.19-C$68.50M-C$0.37-26.11ExtendicareC$1.39B0.61C$59.44MC$0.6814.91 Do insiders and institutionals hold more shares of DNTL or EXE? 50.3% of dentalcorp shares are held by institutional investors. Comparatively, 19.2% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate DNTL or EXE? dentalcorp presently has a consensus target price of C$11.00, indicating a potential upside of 13.87%. Extendicare has a consensus target price of C$9.50, indicating a potential downside of 6.31%. Given dentalcorp's stronger consensus rating and higher possible upside, research analysts plainly believe dentalcorp is more favorable than Extendicare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score dentalcorp 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Extendicare 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to DNTL or EXE? In the previous week, Extendicare had 5 more articles in the media than dentalcorp. MarketBeat recorded 9 mentions for Extendicare and 4 mentions for dentalcorp. Extendicare's average media sentiment score of 0.85 beat dentalcorp's score of 0.69 indicating that Extendicare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment dentalcorp 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Extendicare 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryExtendicare beats dentalcorp on 10 of the 17 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Extendicare News Delivered to You Automatically Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXE vs. The Competition Export to ExcelMetricExtendicareMedical Care Facilities IndustryMedical SectorTSE ExchangeMarket CapC$846.39MC$1.41BC$5.10BC$6.13BDividend Yield5.14%3.79%5.20%5.35%P/E Ratio14.91207.7688.4525.89Price / Sales0.6161.401,244.691,442.58Price / Cash3.2013.4540.0382.51Price / Book7.922.276.493.07Net IncomeC$59.44MC$52.03MC$116.34MC$293.09M7 Day Performance7.76%-0.85%-5.14%-0.14%1 Month Performance9.03%-1.90%-2.71%-1.48%1 Year Performance56.72%12.05%31.26%42.74% Extendicare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXEExtendicare1.2237 of 5 starsC$10.14+1.3%C$9.50-6.3%+57.9%C$846.39MC$1.39B14.9123,000Analyst ForecastAnalyst RevisionNews CoverageDNTLdentalcorp0.9387 of 5 starsC$10.32-0.1%N/A+75.0%C$1.86BC$1.47B-27.899,950Analyst ForecastNews CoverageHigh Trading VolumeSIASienna Senior Living1.6195 of 5 starsC$17.08+0.6%N/A+51.6%C$1.41BC$844.19M43.7912,000Analyst ForecastAnalyst RevisionNews CoverageWELLWELL Health Technologies2.2811 of 5 starsC$4.97-6.9%N/A+31.0%C$1.24BC$910.42M8.72510High Trading VolumeDRMedical Facilities0.5814 of 5 starsC$14.61+2.0%N/A+85.2%C$351.37MC$441.27M13.281,833Analyst RevisionKDAKDA GroupN/AC$0.22+7.5%N/A+65.4%C$37.71MC$28.71M-7.503,100Gap UpNLHNova Leap HealthN/AC$0.31-1.6%N/A+30.0%C$26.29MC$25.87M-15.25N/AGap UpPHAPremier Health of America2.727 of 5 starsC$0.14-3.4%N/A-63.2%C$7.77MC$148.14M-0.64N/ANews CoverageGap DownBLUBELLUS HealthN/AC$19.48-0.1%N/AN/AC$2.47BC$16,000.00-20.2974TRILTrillium TherapeuticsN/AN/AN/AN/AC$2.45BC$43,000.00-34.0633TLRYTilray Brands0.6902 of 5 starsC$1.95-6.7%N/A-20.5%C$1.71BC$788.94M-4.332,650News CoverageGap Down Related Companies and Tools Related Companies dentalcorp Alternatives Sienna Senior Living Alternatives WELL Health Technologies Alternatives Medical Facilities Alternatives KDA Group Alternatives Nova Leap Health Alternatives Premier Health of America Alternatives BELLUS Health Alternatives Trillium Therapeutics Alternatives Tilray Brands Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:EXE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.